Pure Global

NGAL Fast Test Kit - India CDSCO Medical Device Registration

NGAL Fast Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000153_058a6d897b1cb61c81a1123d58269d97_606e768bece5a9b0bfb2dceab07e8944. This device is marketed under the brand name Immunofluorescence Assay. The license holder is Cipla Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
NGAL Fast Test Kit
UID: IMP/IVD/2022/000153_058a6d897b1cb61c81a1123d58269d97_606e768bece5a9b0bfb2dceab07e8944

Brand Name

Immunofluorescence Assay

License Holder

Cipla Limited

Device Class

Class B

Approving Authority

CDSCO

Product Information

As an aid in the early diagnosis of acute kidney injury, risk classification and treatment monitoring

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing